| Thursday
July 2nd |
 |
| |
 |
Introductory session |
|
| 14.00 |
|
Osteoclasts - Anna Teti (L'Aquila,
Italy) |
|
| 14.30 |
|
Osteoblasts - Pierre Marie
(Paris, France) |
|
| 15.00 |
|
Bone metabolism and calciotropic
hormones - Richard Eastell (Sheffield, UK) |
|
| 15.45 |
|
Coffee |
|
| 16.15 |
|
Osteoporosis - Bente Langdahl
(Aarhus, Denmark) |
|
| 16.45 |
|
Other bone diseases - Juliet
Compston (Cambridge, UK) |
|
| 17.30 |
|
Break |
|
| 17.45 |
|
Creative writing - Rebecca
Abrams (Oxford, UK) |
|
| 19.00 |
|
Dinner |
|
| |
| Friday
July 3rd |
|
| 8.30 |
|
Session 1:
Stem cells and bone regeneration - Paolo Bianco
(Rome, Italy) |
|
| 9.15 |
|
Fracture healing and pharmacological
manipulation thereof - Peter Schwarz (Copenhagen,
Denmark) |
|
| 10.00 |
|
Coffee |
|
| 10.30 |
|
Session 2:
Biomechanics and mechanobiology of bone - Tim Skerry
(Sheffield, UK |
|
| 11.15 |
|
Sclerosing bone disorders
–Stuart Ralston (Edinburgh, UK) |
|
| 12.00 |
|
Students’ presentations
5 minutes each |
| |
|
Mr Hermann Agis
Vienna, Austria
Cellular mechanisms of guided bone regeneration:
The impact of platelets and biomaterials in vitro |
| |
|
Dr Nerea Alonso Lopez
Edinburgh, UK
Phenotypic characterisation of RANK mutation knock-in
mice |
| |
|
Dr Elisa Benasciutti
Milan, Italy
Mouse genetics models reveal MHC class II transactivator
as a novel regulator of osteoclastogenesis and bone
homeostasis co-opted from adaptive immunity |
| |
|
Mr Mattia Capulli
L'Aquila, Italy
Mechanisms of bone remodeling regulated by mechanical
forces |
| |
|
Jana Dragojevic
Ljubljana, Slovenia
The role of PPARX in bone metabolism |
| |
|
Miss Katarzyna Gurzawska
Copenhagen, Denmark
Coating of bone implants |
| |
|
Mr El Mustapha Haddouti
Bonn, Germany
Mesenchymal stem cells potential in tissue engineering
for bone regeneration |
|
| 12.45 |
|
LUNCH |
|
| 13.45 |
|
Students’ presentations
(cont)
5 minutes each |
| |
|
Dr Jannie Dahl Hald
Aarhus, Denmark
Osteogenesis Imperfecta - genetics, phenotype and
medical treatment |
| |
|
Dr Torben Harsløf
Aarhus, Denmark
The role of peroxisome proliferator-activated receptor
gamma and its ligands in osteoporosis |
| |
|
Liesbet Lieben
Leuven, Belgium
1,25OH2D3 signaling in the intestine and bone |
| |
|
Katie Marchbank
London, UK
Role of Nbr1 in bone remodeling |
| |
|
Dr Silvia Marino
Orbassano, Italy
Pharmacological treatment of bone fracture healing |
| |
|
Mr David Mellis
Aberdeen, UK
To study the cellular and molecular mechanisms behind
Paget's Disease of Bone caused by mutations in the
RANK gene |
| |
|
Miss Martiene Moester
Leiden, The Netherlands
Modulation of sclerostin expression in osteoporosis |
|
| 15.00 |
|
Coffee |
|
| 15.30 |
|
Session 3: Techniques
PPARgamma.- Hans van Leeuwen (Rotterdam, The Netherlands) |
|
| 16.15 |
|
Cadherin-Wnt interaction -
Pierre Marie (Paris, France) |
|
| 17.00 |
|
End of day |
|
| 19.00 |
|
Dinner |
| |
| Saturday
July 4th |
|
| 8.30 |
|
Session 4:
Interaction between bone and fat tissue - Moustapha
Kassem (Odense, Denmark)
|
|
| 9.15 |
|
Interaction between bone and
the central nervous system - Forent Elefteriou (Nashville,
USA) |
|
| 10.00 |
|
Coffee |
|
| 10.30 |
|
Session 5:
Epigenetics - Rahul Tare (Southampton, UK) |
|
| 11.15 |
|
gp130 signalling in bone cell
biology - Nathalie Sims (Melbourne, Australia) |
|
| 12.00 |
|
Students’ presentations
5 minutes each |
| |
|
Mrs Kristine Møller
Aarhus, Denmark
Calcium homeostasis and bone metabolism during pregnancy
and lactation |
| |
|
Mrs Priscilla Morethson
São Paulo, Brazil
Proton and chloride transport in primary rat osteoclasts:
effects of alendronate and calcitonin |
| |
|
Brian Nicholls
London UK
The role of AKT in mediating the adaptive response
of osteoblasts in mechanical strain |
| |
|
Miss Pamela Pail
Vienna, Austria
Mechanisms of osteoblast-osteoclast signalling |
| |
|
Miss Lianne Reddie
Manchester, UK
The metaphyseal index as a tool for the assessment
of distal radius development |
| |
|
Dr Roberta Scianaro
Rome, Italy
Role of the immune system in bone resorption: does
the mineralized matrix induce an osteoclast-activating
“danger signal”?” |
| |
|
Amir-Shaya Sharili
London, UK
The role of the transcription factor snail 2 in
bone cancer and repair |
|
| 12.45 |
|
LUNCH |
|
| 13.45 |
|
Students’ presentations
(cont)
5 minutes each |
| |
|
Ms Tanja Tvistholm Sikjaer
Aarhus, Denmark
Treatment of hypoparathyroidism with subcutaneous
PTH 1-84 injections: effects on muscle function
and quality of life |
| |
|
Miss Katherine Staines
Midlothian, Scotland
Unravelling the regulatory mechanisms controlling
inorganic phosphate mobilisation during growth plate
mineralisation and bone development |
| |
|
Ms Susanna við Streym
Thomsen Horsens, Denmark
Fetal status of Vitamin D - a risk factor for disease? |
| |
|
Dr Karolina Turzanska
Lublin, Poland
Bioavailability of Strontium administered orally
to growing mice as ranelate versus chloride |
| |
|
Mrs Karen van der Meijden
Utrecht, The Netherlands
Extrarenal hydroxylation of 25-hydroxyvitamin: stimulation
by 25-hydroxyvitamin D and by mechanical forces. |
| |
|
Dr Martina Winkler-Krottmaier
Vienna, Austria
Characterization and assessment of risk factors
of hip fracture patients |
| |
|
Mrs Elisabeth Ytteborg Ås
Norway
Characterization of mechanisms involved in development
of vertebral deformities in Atlantic salmon Salmo
salar |
|
| 15.00 |
|
Coffee |
|
| 15.30 |
|
Session 6: Animal
models
Quantification of gene expression - Alun Hughes
(Aberdeen, UK)
Structure and mineralisation of bone and cartilage
- Alan Boyde (London, UK) |
|
| 16.15 |
|
Structure and mineralisation
of bone and cartilage - Alan Boyde (London, UK) |
|
| |
|
End of day |
|
| 19.00 |
|
Dinner |
|
| |
| Sunday
July 5th |
|
| 9.00 |
|
Session 7:
Assessment of fracture risk - Eugene McCloskey (Sheffield,
UK) |
|
| 09.45 |
|
The ubiquitin proteasome system
in bone biology - Rob Layfield (Nottingham, UK) |
|
| 10.30 |
|
Coffee |
|
| 11.00 |
|
Session 8:
Pharmacological manipulation of osteoclasts - Frazer
Coxon (Aberdeen, UK) |
|
| 11.45 |
|
Bone cell signaling: In sickness
and in health - Aymen Idris (Edinburgh, UK) |
|
| 12.45 |
|
Lunch |
|
| 13.45 |
|
Adjourn |
|
| |
|
|
| |
|
4th International
Workshop on the Molecular Pharmacology and Therapeutics
of Bone Disease -
www.molpharm2009.org |
|
| |
|
FREE PLACES are available
to 10 students who register on this PhD training
course
to attend the 4th International Workshop on Advances
in Molecular Pharmacology and Therapeutics of
Bone Disease 6-8 July 2009 -
Speakers and other faculty members at the
4th International Workshop are to include:
Roland Baron (Boston, USA)
Lynda Bonewald (Kansas City, USA)
Matt Brown (Brisbane, Australia)
Henry Bryant (Indianapolis, USA)
Tim Cundy (Auckland, New Zealand)
Anna Daroszewska (Edinburgh, UK)
Patricia Ducy (New York, USA)
Richard Eastell (Sheffield, UK)
Hal Ebetino (Cincinnati, USA)
James Edwards (Nashville, USA)
Serge Ferrari (Geneva, Switzerland)
Nathalie Franchimont (Lucerne, Switzerland)
Francis Glorieux (Montreal, Canada)
David Goltzman (Montreal, Canada)
David Hosking (Nottingham, UK)
Aymen Idris (Edinburgh, UK)
Morten Karsdal (Herlev, Denmark)
Gerard Karsenty (New York, USA)
Sundeep Khosla (Rochester, USA)
Michaela Kneissel (Basel, Switzerland)
Paul Kostenuik (Thousand Oaks, USA)
Steven Krane (Boston, USA)
Clemens Löwik (Leiden, Netherlands)
Jack Martin (Melbourne, Australia)
Eugene McCloskey (Sheffield, UK)
Udo Oppermann (Oxford, UK)
Socrates Papapoulos (Leiden, Netherlands)
Stuart Ralston (Edinburgh, UK)
David Roodman (Pittsburgh, USA)
Cliff Rosen (Maine, USA)
Graham Russell (Oxford, UK)
Natalie Sims (Melbourne, Australia)
Raj Thakker (Oxford, UK)
Wim Van Hul (Antwerp, Belgium)
|
|
